• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

T337M 和 G391V 疾病相关变异对人磷酸葡糖变位酶 1 的影响:大、小结构破坏。

Effects of the T337M and G391V disease-related variants on human phosphoglucomutase 1: structural disruptions large and small.

机构信息

Biochemistry Department, University of Missouri, Columbia, MO 65211, USA.

出版信息

Acta Crystallogr F Struct Biol Commun. 2022 May 1;78(Pt 5):200-209. doi: 10.1107/S2053230X22004174. Epub 2022 Apr 25.

DOI:10.1107/S2053230X22004174
PMID:35506765
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9067374/
Abstract

Phosphoglucomutase 1 (PGM1) plays a central role in glucose homeostasis in human cells. Missense variants of this enzyme cause an inborn error of metabolism, which is categorized as a congenital disorder of glycosylation. Here, two disease-related variants of PGM1, T337M and G391V, which are both located in domain 3 of the four-domain protein, were characterized via X-ray crystallography and biochemical assays. The studies show multiple impacts resulting from these dysfunctional variants, including both short- and long-range structural perturbations. In the T337M variant these are limited to a small shift in an active-site loop, consistent with reduced enzyme activity. In contrast, the G391V variant produces a cascade of structural perturbations, including displacement of both the catalytic phosphoserine and metal-binding loops. This work reinforces several themes that were found in prior studies of dysfunctional PGM1 variants, including increased structural flexibility and the outsized impacts of mutations affecting interdomain interfaces. The molecular mechanisms of PGM1 variants have implications for newly described inherited disorders of related enzymes.

摘要

磷酸葡萄糖变位酶 1(PGM1)在人类细胞的葡萄糖稳态中发挥核心作用。该酶的错义变体导致先天性代谢错误,被归类为糖基化先天性疾病。在这里,通过 X 射线晶体学和生化分析研究了两种位于四结构域蛋白结构域 3 的与疾病相关的 PGM1 变体,T337M 和 G391V。研究表明,这些功能失调变体导致多种影响,包括短程和长程结构扰动。在 T337M 变体中,这些结构扰动仅限于活性位点环的小位移,与酶活性降低一致。相比之下,G391V 变体产生一连串的结构扰动,包括催化磷酸丝氨酸和金属结合环的位移。这项工作强化了先前对功能失调的 PGM1 变体研究中发现的几个主题,包括结构灵活性增加以及影响结构域间界面的突变的巨大影响。PGM1 变体的分子机制对新描述的相关酶的遗传性疾病具有重要意义。

相似文献

1
Effects of the T337M and G391V disease-related variants on human phosphoglucomutase 1: structural disruptions large and small.T337M 和 G391V 疾病相关变异对人磷酸葡糖变位酶 1 的影响:大、小结构破坏。
Acta Crystallogr F Struct Biol Commun. 2022 May 1;78(Pt 5):200-209. doi: 10.1107/S2053230X22004174. Epub 2022 Apr 25.
2
A missense variant remote from the active site impairs stability of human phosphoglucomutase 1.一个远离活性位点的错义变体损害了人类磷酸葡萄糖变位酶1的稳定性。
J Inherit Metab Dis. 2020 Jul;43(4):861-870. doi: 10.1002/jimd.12222. Epub 2020 Feb 18.
3
A Hotspot for Disease-Associated Variants of Human PGM1 Is Associated with Impaired Ligand Binding and Loop Dynamics.一个与人类 PGM1 相关疾病变异的热点与配体结合和环动态的损伤有关。
Structure. 2018 Oct 2;26(10):1337-1345.e3. doi: 10.1016/j.str.2018.07.005. Epub 2018 Aug 16.
4
Asp263 missense variants perturb the active site of human phosphoglucomutase 1.Asp263 错义变异会破坏人磷酸葡糖变位酶 1 的活性部位。
FEBS J. 2017 Mar;284(6):937-947. doi: 10.1111/febs.14025. Epub 2017 Feb 10.
5
Induced Structural Disorder as a Molecular Mechanism for Enzyme Dysfunction in Phosphoglucomutase 1 Deficiency.诱导结构紊乱作为磷酸葡萄糖变位酶1缺乏症中酶功能障碍的分子机制。
J Mol Biol. 2016 Apr 24;428(8):1493-505. doi: 10.1016/j.jmb.2016.02.032. Epub 2016 Mar 10.
6
Enzyme dysfunction at atomic resolution: Disease-associated variants of human phosphoglucomutase-1.原子分辨率下的酶功能障碍:人磷酸葡糖变位酶-1 的疾病相关变体。
Biochimie. 2021 Apr;183:44-48. doi: 10.1016/j.biochi.2020.08.017. Epub 2020 Sep 6.
7
Mutations in hereditary phosphoglucomutase 1 deficiency map to key regions of enzyme structure and function.遗传性磷酸葡萄糖变位酶1缺乏症中的突变定位于酶结构和功能的关键区域。
J Inherit Metab Dis. 2015 Mar;38(2):243-56. doi: 10.1007/s10545-014-9757-9. Epub 2014 Aug 29.
8
Compromised catalysis and potential folding defects in in vitro studies of missense mutants associated with hereditary phosphoglucomutase 1 deficiency.与遗传性磷酸葡萄糖变位酶1缺乏症相关的错义突变体体外研究中的催化受损和潜在折叠缺陷。
J Biol Chem. 2014 Nov 14;289(46):32010-32019. doi: 10.1074/jbc.M114.597914. Epub 2014 Oct 6.
9
Structural basis for substrate and product recognition in human phosphoglucomutase-1 (PGM1) isoform 2, a member of the α-D-phosphohexomutase superfamily.人磷酸葡萄糖变位酶 1(PGM1)同工型 2 的底物和产物识别的结构基础,该酶是 α-D-磷酸己糖变位酶超家族的成员。
Sci Rep. 2020 Mar 27;10(1):5656. doi: 10.1038/s41598-020-62548-0.
10
Glycogen storage disease-like phenotype with central nervous system involvement in a PGM1-CDG patient.一名PGM1-CDG患者出现类似糖原贮积病的表型并累及中枢神经系统。
Neuro Endocrinol Lett. 2014;35(2):137-41.

本文引用的文献

1
Impaired glucose-1,6-biphosphate production due to bi-allelic PGM2L1 mutations is associated with a neurodevelopmental disorder.由于 PGM2L1 基因的双等位基因突变导致的葡萄糖-1,6-二磷酸生成受损与神经发育障碍有关。
Am J Hum Genet. 2021 Jun 3;108(6):1151-1160. doi: 10.1016/j.ajhg.2021.04.017. Epub 2021 May 11.
2
Two Novel Homozygous Mutations in Phosphoglucomutase 3 Leading to Severe Combined Immunodeficiency, Skeletal Dysplasia, and Malformations.两种新型磷酸葡萄糖变位酶 3 纯合突变导致严重联合免疫缺陷、骨骼发育不良和畸形。
J Clin Immunol. 2021 Jul;41(5):958-966. doi: 10.1007/s10875-021-00985-w. Epub 2021 Feb 3.
3
Galactose treatment of a PGM1 patient presenting with restrictive cardiomyopathy.用半乳糖治疗一名患有限制型心肌病的磷酸葡萄糖变位酶1缺乏症患者。
JIMD Rep. 2020 Oct 19;57(1):29-37. doi: 10.1002/jmd2.12177. eCollection 2021 Jan.
4
Heterozygous Variants Are Associated With Idiopathic Focal Epilepsy With Incomplete Penetrance.杂合变异与不完全外显的特发性局灶性癫痫相关。
Front Genet. 2020 Oct 15;11:559080. doi: 10.3389/fgene.2020.559080. eCollection 2020.
5
Global view of human protein glycosylation pathways and functions.人类蛋白糖基化途径和功能的全球视图。
Nat Rev Mol Cell Biol. 2020 Dec;21(12):729-749. doi: 10.1038/s41580-020-00294-x. Epub 2020 Oct 21.
6
Enzyme dysfunction at atomic resolution: Disease-associated variants of human phosphoglucomutase-1.原子分辨率下的酶功能障碍:人磷酸葡糖变位酶-1 的疾病相关变体。
Biochimie. 2021 Apr;183:44-48. doi: 10.1016/j.biochi.2020.08.017. Epub 2020 Sep 6.
7
International consensus guidelines for phosphoglucomutase 1 deficiency (PGM1-CDG): Diagnosis, follow-up, and management.国际磷酸葡萄糖变位酶 1 缺乏症(PGM1-CDG)共识指南:诊断、随访和管理。
J Inherit Metab Dis. 2021 Jan;44(1):148-163. doi: 10.1002/jimd.12286. Epub 2020 Sep 15.
8
Structural basis for substrate and product recognition in human phosphoglucomutase-1 (PGM1) isoform 2, a member of the α-D-phosphohexomutase superfamily.人磷酸葡萄糖变位酶 1(PGM1)同工型 2 的底物和产物识别的结构基础,该酶是 α-D-磷酸己糖变位酶超家族的成员。
Sci Rep. 2020 Mar 27;10(1):5656. doi: 10.1038/s41598-020-62548-0.
9
A missense variant remote from the active site impairs stability of human phosphoglucomutase 1.一个远离活性位点的错义变体损害了人类磷酸葡萄糖变位酶1的稳定性。
J Inherit Metab Dis. 2020 Jul;43(4):861-870. doi: 10.1002/jimd.12222. Epub 2020 Feb 18.
10
The Metabolic Map into the Pathomechanism and Treatment of PGM1-CDG.PGM1-CDG 的代谢图谱与发病机制及治疗
Am J Hum Genet. 2019 May 2;104(5):835-846. doi: 10.1016/j.ajhg.2019.03.003. Epub 2019 Apr 11.